Citation: Ew. Smith et al., EVALUATION OF THE PROPOSED FDA PILOT DOSE-RESPONSE METHODOLOGY FOR TOPICAL CORTICOSTEROID BIOEQUIVALENCE TESTING - AUTHORS REPLY, Pharmaceutical research, 15(1), 1998, pp. 5-7
Citation: M. Skinner et I. Kanfer, COMPARATIVE BIOAVAILABILITY OF JOSAMYCIN, A MACROLIDE ANTIBIOTIC, FROM A TABLET AND SOLUTION AND THE INFLUENCE OF DISSOLUTION ON IN-VIVO RELEASE, Biopharmaceutics & drug disposition, 19(1), 1998, pp. 21-29
Citation: Ak. Lalloo et al., DEVELOPMENT OF A CAPILLARY ELECTROPHORETIC METHOD FOR THE SEPARATION OF THE MACROLIDE ANTIBIOTICS, ERYTHROMYCIN, JOSAMYCIN AND OLEANDOMYCIN, Journal of chromatography B. Biomedical sciences and applications, 704(1-2), 1997, pp. 333-341
Citation: Ak. Lalloo et I. Kanfer, DETERMINATION OF ERYTHROMYCIN AND RELATED SUBSTANCES BY CAPILLARY ELECTROPHORESIS, Journal of chromatography B. Biomedical sciences and applications, 704(1-2), 1997, pp. 343-350
Authors:
DEMANA PH
SMITH EW
WALKER RB
HAIGH JM
KANFER I
Citation: Ph. Demana et al., EVALUATION OF THE PROPOSED FDA PILOT DOSE-RESPONSE METHODOLOGY FOR TOPICAL CORTICOSTEROID BIOEQUIVALENCE TESTING, Pharmaceutical research, 14(3), 1997, pp. 303-308
Citation: Jm. Haigh et al., THE HUMAN SKIN BLANCHING ASSAY FOR IN-VIVO TOPICAL CORTICOSTEROID ASSESSMENT .1. REPRODUCIBILITY OF THE ASSAY, International journal of pharmaceutics, 152(2), 1997, pp. 179-183
Citation: Jm. Haigh et al., THE HUMAN SKIN BLANCHING ASSAY FOR IN-VIVO TOPICAL CORTICOSTEROID ASSESSMENT .2. SUBJECT-DEPENDENT AND OBSERVER-DEPENDENT VARIATION IN BLANCHING RESPONSES, International journal of pharmaceutics, 152(2), 1997, pp. 185-192
Citation: V. Vuma et I. Kanfer, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF PHENYLEPHRINE IN HUMAN SERUM WITH COULOMETRIC DETECTION, Journal of chromatography B. Biomedical applications, 678(2), 1996, pp. 245-252
Citation: Rb. Walker et I. Kanfer, PHARMACOKINETICS OF CYCLIZINE FOLLOWING INTRAVENOUS ADMINISTRATION TOHUMAN VOLUNTEERS, European journal of pharmaceutical sciences, 4(5), 1996, pp. 301-306
Citation: I. Kanfer et al., ABSORPTION OF SULINDAC FROM A NOVEL (PRO-SORB(TM)) LIQUID FORMULATION, Biopharmaceutics & drug disposition, 17(3), 1996, pp. 209-221
Citation: Rb. Walker et I. Kanfer, SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF CYCLIZINE AND ITS DEMETHYLATED METABOLITE, NORCYCLIZINE, IN BIOLOGICAL-FLUIDS USING COULOMETRIC DETECTION, Journal of chromatography B. Biomedical applications, 672(1), 1995, pp. 172-177
Citation: Sc. Chattaraj et I. Kanfer, RELEASE OF ACYCLOVIR FROM SEMISOLID DOSAGE FORMS - A SEMIAUTOMATED PROCEDURE USING A SIMPLE PLEXIGLASS FLOW-THROUGH CELL, International journal of pharmaceutics, 125(2), 1995, pp. 215-222
Citation: Sc. Chattaraj et al., A SIMPLE DIFFUSION CELL TO MONITOR DRUG-RELEASE FROM SEMISOLID DOSAGEFORMS, International journal of pharmaceutics, 120(1), 1995, pp. 119-124
Citation: Sa. Terespolsky et I. Kanfer, STABILITY OF ERYTHROMYCIN AND SOME OF ITS ESTERS IN METHANOL AND ACETONITRILE, International journal of pharmaceutics, 115(1), 1995, pp. 123-128
Citation: Lagl. Tandt et al., LEVEL A IN VITRO IN VIVO CORRELATIONS - A QUALITY-CONTROL TOOL OR BIOEQUIVALENCE PREDICTOR FOR EXTENDED-RELEASE SOLID ORAL DOSAGE FORMS/, Drug development and industrial pharmacy, 21(8), 1995, pp. 889-904
Citation: Lagl. Tandt et al., THE USE OF DISSOLUTION RATE DATA TO ACCOUNT FOR DIFFERENCES IN THE ABSORPTION PROFILES OF 2 CONTROLLED MODIFIED-RELEASE CAPSULE DOSAGE FORMS OF INDOMETHACIN IN HUMAN VOLUNTEERS/, International journal of pharmaceutics, 104(1), 1994, pp. 11-17
Citation: M. Skinner et al., THE PH-STABILITY AND ACID DEGRADATION OF THE MACROLIDE ANTIBIOTIC, JOSAMYCIN, European journal of pharmaceutical sciences, 1(2), 1993, pp. 61-72